You are here: Industry Insights > FDA

News List

Zydus Cadila gets US FDA nod to market anti-obesity drug financialexpress
July 03, 2017
The drug will be produced at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Rise in product recalls prompts FDA to warn of possible BCC contamination europeanpharmaceuticalreview
July 03, 2017
The US Food and Drug Administration (FDA) has advised manufacturers of non-sterile, water-based drug products that there have been recent product recalls due to Burkholderia cepacia complex (BCC) contamination.
Data Analysis of Relevant Warning Letters of FDA on Computer System en-cphi.cn
June 30, 2017
As is known to all, FDA, one of the strictest drug administration agencies in the world, mainly take charge of safeguarding the health and safety of consumers based on federal food, drug, cosmetics laws and other laws.
FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 Disorder firstwordpharma
June 30, 2017
FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 Disorder
FDA Approves Vectibix (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer firstwordpharma
June 30, 2017
FDA Approves Vectibix (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer
FDA creates team to tackle backlog of orphan drug designation requests firstwordpharma
June 30, 2017
FDA creates team to tackle backlog of orphan drug designation requests
FDA Grants Priority Review of 10 mg XARELTO to Reduce VTE Risk americanpharmaceuticalreview
June 29, 2017
Janssen Research & Development announced the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) to include a 10 mg once-daily dose for reducing the risk of VTE after at
FDA grants fast track designation to Synlogic’s SYNB1020 synthetic biotic treatment pharmaceutical-technology
June 29, 2017
Synlogic has received fast track designation for its lead product candidate SYNB1020 from the US Food and Drug Administration (FDA).
US FDA approves Natco’s ANDA for generic version of Vidaza expressbpd
June 29, 2017
Natco and Breckenridge Pharmaceutical plan to launch the product in the US market
FDA tackles drug competition to improve patient access worldpharmanews
June 29, 2017
Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page